Physician profile
Cynthia Abbott
NPI 1902898315
$2,565.01
in general payments reported to CMS, 2019-2025
17 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $87.04 · 2021: $459 · 2022: $102 · 2023: $436 · 2024: $280 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Education: $63.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.97 |
| Education | $63.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,017.09 | 2019 | |
| Abbvie INC. | $568.11 | 2021-2025 | Skyrizi, Rinvoq |
| Regeneron Healthcare Solutions, INC. | $278.27 | 2019-2022 | |
| Galderma Laboratories, L.P. | $123.84 | 2020-2024 | |
| Arcutis Biotherapeutics, INC. | $100.23 | 2024 | Zoryve |
| Janssen Biotech, INC. | $88.48 | 2021-2023 | Tremfya |
| Ucb, INC. | $87.72 | 2023-2025 | Bimzelx, Cimzia |
| Mayne Pharma Commercial LLC | $52.23 | 2021-2023 | |
| Genzyme Corporation | $50.03 | 2020-2021 | |
| Botanix Sb INC | $33.15 | 2025 | Sofdra |
| Sun Pharmaceutical Industries INC. | $30.23 | 2022 | |
| Verrica Pharmaceuticals INC. | $28.89 | 2023 | Ycanth |
| Amgen INC. | $28.72 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $22.50 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $20.27 | 2024 | Sotyktu |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.61 | 2021 | |
| Medtronic, INC. | $15.64 | 2023 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Abbott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.